EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Estimating meaningful change thresholds for Skin Pain‐Numeric Rating Scale, Sleep‐Numeric Rating Scale and Dermatology Life Quality Index in patients with prurigo nodularis

S Stander iD, B S Kim, I Guillemin, S Rhoten, S Wratten, E Brookes, J T O'Malley, A Bansal iD, J Msihid, R Thomas, D Bahloul iD

Journal of the European Academy of Dermatology and Venereology · 2024

DOI: 10.1111/jdv.19800 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von S Stander und 10 weiteren Autor:innen. Beteiligte Einrichtung: University Clinic Münster, Münster, Germany. Hauptthemen laut MEDLINE: Pain Measurement, Patient Reported Outcome Measures, Prurigo, Quality of Life. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Regeneron Pharmaceuticals, Sanofi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prurigo nodularis (PN) is characterized by intensely itchy nodules/lesions and skin pain, which can have a substantial impact on health‐related quality of life (HRQoL). Treatment benefits on such symptoms and impacts are best assessed in trials using patient‐reported outcome (PROs) instruments such as Skin Pain Numerical Rating Scale (NRS), Sleep‐NRS and Dermatology Life Quality Index (DLQI). However, no guidance exists for interpreting meaningful changes in scores using these PROs in patients with PN.

Objectives

The main objective was to derive within‐patient (responder definition) and between‐group improvement thresholds for interpreting Skin Pain‐NRS, Sleep‐NRS and DLQI total scores in patients with PN. The measurement properties of the three PROs were also evaluated.

Methods

Intention‐to‐treat (ITT), blinded and pooled data were used from the Phase 3 PRIME (NCT04183335) and PRIME2 (NCT04202679) studies evaluating the efficacy of dupilumab in adult patients with PN. Anchor‐ and distribution‐based methods were applied to derive responder definition and between‐group thresholds for Skin Pain‐NRS, Sleep‐NRS and DLQI. Data were additionally used to examine the instrument measurement properties, including reliability, validity and responsiveness.

Results

A total of 311 patients (mean age 49.5 years, 65.3% female) were included in the pooled ITT population. The within‐patient improvement threshold for Skin Pain‐NRS was estimated as 4.0 points, 2.0 points for Sleep‐NRS and 9.0 points for DLQI total score. A 1.5‐point improvement in Skin Pain‐NRS scores, 1.0‐point in Sleep‐NRS and 4.0‐point in DLQI indicated a between‐group meaningful change. Adequate to good psychometric properties were demonstrated for all three instruments.

Conclusions

The results of this study can aid interpretation of Skin Pain‐NRS, Sleep‐NRS and DLQI scores in patients with PN in both clinical trials and clinical practice to better understand and treat PN‐related skin pain and the impact of PN on sleep quality and HRQoL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pain MeasurementPatient Reported Outcome MeasuresPrurigoQuality of LifeAdultFemaleHumansMaleMiddle AgedAntibodies, Monoclonal, HumanizedPainSleep

Substanzen

Antibodies, Monoclonal, Humanizeddupilumab

Autor:innen und Institutionen

  • University Clinic Münster, Münster, Germany.
  • Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • IQVIA, Lyon, France.
  • IQVIA, San Francisco, California, USA.
  • IQVIA, Manchester, UK.
  • Sanofi, Reading, UK.

ORCID-Profile: S Stander, A Bansal, D Bahloul

Förderung

  • Regeneron Pharmaceuticals
  • Sanofi

Zitieren

APA

Stander, S., Kim, B. S., Guillemin, I., Rhoten, S., Wratten, S., Brookes, E., O'Malley, J. T., Bansal, A., Msihid, J., Thomas, R., & Bahloul, D. (2024). Estimating meaningful change thresholds for Skin Pain‐Numeric Rating Scale, Sleep‐Numeric Rating Scale and Dermatology Life Quality Index in patients with prurigo nodularis. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19800

Vancouver

Stander S, Kim BS, Guillemin I, Rhoten S, Wratten S, Brookes E, et al. Estimating meaningful change thresholds for Skin Pain‐Numeric Rating Scale, Sleep‐Numeric Rating Scale and Dermatology Life Quality Index in patients with prurigo nodularis. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19800

BibTeX
@article{Stander2024,
  author = {Stander, S and Kim, B S and Guillemin, I and Rhoten, S and Wratten, S and Brookes, E and O'Malley, J T and Bansal, A and Msihid, J and Thomas, R and Bahloul, D},
  title = {Estimating meaningful change thresholds for Skin Pain‐Numeric Rating Scale, Sleep‐Numeric Rating Scale and Dermatology Life Quality Index in patients with prurigo nodularis},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2024},
  doi = {10.1111/jdv.19800}
}
Kostenlos starten →